tobradex augndropar, dreifa
novartis healthcare a/s - dexamethasonum fosfat; tobramycinum inn - augndropar, dreifa
xalatan augndropar, lausn 50 míkróg/ml
upjohn eesv - latanoprostum inn - augndropar, lausn - 50 míkróg/ml
madopar hart hylki 100 mg og 25 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart hylki - 100 mg og 25 mg
madopar hart hylki 50 mg og 12,5 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart hylki - 50 mg og 12,5 mg
madopar tafla 125 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - tafla - 125 mg
madopar depot hart forðahylki 100 mg/25 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart forðahylki - 100 mg/25 mg
madopar quick lausnartafla 100 mg/25 mg
roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 100 mg/25 mg
madopar quick lausnartafla 50 mg/12,5 mg
roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 50 mg/12,5 mg
hydrocortison med terramycin og polymyxin b eyrna-/augndropar, dreifa
pfizer aps - polymyxinum b súlfat; oxytetracyclinum hýdróklóríð; hydrocortisonum acetat - eyrna-/augndropar, dreifa
cyclogyl 1% augndropar, lausn 10 mg/ ml
alcon nordic a/s - cyclopentolatum hýdróklóríð - augndropar, lausn - 10 mg/ ml